Form 8-K - Current report:
SEC Accession No. 0001193125-25-158493
Filing Date
2025-07-14
Accepted
2025-07-14 09:14:24
Documents
16
Period of Report
2025-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d89351d8k.htm   iXBRL 8-K 48806
2 EX-2.1 d89351dex21.htm EX-2.1 783264
3 EX-99.1 d89351dex991.htm EX-99.1 13301
8 GRAPHIC g89351g0713233733162.jpg GRAPHIC 4542
  Complete submission text file 0001193125-25-158493.txt   1174845

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prgo-20250713.xsd EX-101.SCH 4438
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20250713_def.xml EX-101.DEF 15358
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20250713_lab.xml EX-101.LAB 26310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20250713_pre.xml EX-101.PRE 16431
18 EXTRACTED XBRL INSTANCE DOCUMENT d89351d8k_htm.xml XML 10803
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 251120271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)